Skip to main content
. 2021 Feb 11;13(2):250. doi: 10.3390/pharmaceutics13020250

Figure 3.

Figure 3

Morphology change of NCCP16283. SEM images (40.0 kx magnification) of NCCP16283 after (a) non-treatment and treatment of (b) PolB (0.2 μg·mL−1) with NZB (62.5 μg·mL−1). Images are one of the representatives from n = 8. White arrows indicate the disruption of bacterial cells.